|
1
|
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis.
|
J Crohns Colitis
|
2010
|
3.97
|
|
2
|
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations.
|
J Crohns Colitis
|
2009
|
3.66
|
|
3
|
Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases.
|
Inflamm Bowel Dis
|
2007
|
2.89
|
|
4
|
Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis.
|
Proc Natl Acad Sci U S A
|
2006
|
2.31
|
|
5
|
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations.
|
J Crohns Colitis
|
2012
|
1.71
|
|
6
|
Management of pediatric ulcerative colitis: joint ECCO and ESPGHAN evidence-based consensus guidelines.
|
J Pediatr Gastroenterol Nutr
|
2012
|
1.52
|
|
7
|
European evidenced-based consensus on reproduction in inflammatory bowel disease.
|
J Crohns Colitis
|
2010
|
1.45
|
|
8
|
European evidence-based Consensus on the management of ulcerative colitis: Special situations.
|
J Crohns Colitis
|
2008
|
1.34
|
|
9
|
Colitis-associated colon tumorigenesis is suppressed in transgenic mice rich in endogenous n-3 fatty acids.
|
Carcinogenesis
|
2007
|
1.23
|
|
10
|
Effects of systemic administration of a local anesthetic on pain in acute pancreatitis: a randomized clinical trial.
|
Pancreas
|
2011
|
1.12
|
|
11
|
Sexual function in persons with inflammatory bowel disease: a survey with matched controls.
|
Clin Gastroenterol Hepatol
|
2007
|
1.02
|
|
12
|
Impact of pain on health-related quality of life in patients with inflammatory bowel disease.
|
World J Gastroenterol
|
2010
|
1.01
|
|
13
|
European evidence based consensus on surgery for ulcerative colitis.
|
J Crohns Colitis
|
2015
|
1.01
|
|
14
|
Galectin-4 controls intestinal inflammation by selective regulation of peripheral and mucosal T cell apoptosis and cell cycle.
|
PLoS One
|
2008
|
0.97
|
|
15
|
The c.1-260C>T promoter variant of CD14 but not the c.896A>G (p.D299G) variant of toll-like receptor 4 (TLR4) genes is associated with inflammatory bowel disease.
|
Digestion
|
2007
|
0.94
|
|
16
|
Psychosocial distress in acute cancer patients assessed with an expert rating scale.
|
Support Care Cancer
|
2010
|
0.92
|
|
17
|
Open label trial of granulocyte apheresis suggests therapeutic efficacy in chronically active steroid refractory ulcerative colitis.
|
World J Gastroenterol
|
2005
|
0.87
|
|
18
|
Enteral and parenteral nutrition distinctively modulate intestinal permeability and T cell function in vitro.
|
Eur J Nutr
|
2008
|
0.86
|
|
19
|
Clinical case reports raise doubts about the therapeutic equivalence of an iron sucrose similar preparation compared with iron sucrose originator.
|
Curr Med Res Opin
|
2012
|
0.84
|
|
20
|
DLG5 variants in inflammatory bowel disease.
|
Am J Gastroenterol
|
2006
|
0.82
|
|
21
|
[Boceprevir-benefit assessment by the Institute for Quality and Efficiency in Health Care (IQWiG) in accordance with § 35a SGB V (dosage evaluation)].
|
Z Gastroenterol
|
2012
|
0.80
|
|
22
|
Management of severe refractory adult autoimmune enteropathy with infliximab and tacrolimus.
|
Digestion
|
2005
|
0.80
|
|
23
|
Quality of life in patients with active ulcerative colitis treated with selective leukocyte apheresis.
|
Scand J Gastroenterol
|
2007
|
0.78
|
|
24
|
Successful infliximab treatment of steroid and OKT3 refractory acute cellular rejection in two patients after intestinal transplantation.
|
Transplantation
|
2003
|
0.77
|
|
25
|
On the second ECCO Consensus on Crohn's disease.
|
J Crohns Colitis
|
2010
|
0.77
|
|
26
|
Mesalazine in left-sided ulcerative colitis: efficacy analyses from the PODIUM trial on maintenance of remission and mucosal healing.
|
J Crohns Colitis
|
2011
|
0.77
|
|
27
|
Experience with a training program for transgastric procedures in NOTES.
|
Surg Endosc
|
2009
|
0.76
|
|
28
|
Reply to Drs. Silva and Santana's letter.
|
J Crohns Colitis
|
2012
|
0.75
|
|
29
|
Mesalamine in the treatment of active Crohn's disease.
|
Gastroenterology
|
2005
|
0.75
|
|
30
|
Late graft loss after intestinal transplantation in an adult patient as a result of necrotizing enterocolitis.
|
Am J Transplant
|
2003
|
0.75
|
|
31
|
Digestive Diseases. Introduction.
|
Dig Dis
|
2014
|
0.75
|